In addition to securing all appropriate approvals, to include approval from the Office of Research, IRB approval must be prospectively obtained prior to the implementation of any proposed research activity involving human subjects.
Human Use Protocol Submission Process:
- The HRPP Office will accept the submission documents via the new eIRB system- iRIS. To access the system, please go to: https://eirb.csd.disa.mil (link is external). To apply for a new account, see the EIRB Reference Guide, for assistance contact the HRPP office.
- The protocol application is a fillable eIRB form. In addition to the protocol, the following required documents may be uploaded, as applicable :
- For all research: Current Curriculum Vitae (CV), CITI human subjects protections training certifications, HIPAA training certification - These forms may be uploaded only once into the researcher’s eIRB profile to avoid being asked for these documents with each new IRB submission.
- For sponsored/ funded research: Financial Disclosure/Conflict of Interest Form
- For non-exempt studies: Proposed informed consent document (ICD) or information sheet unless a waiver of consent or a waiver of documentation of consent is being sought.
- For studies involving protected health information (PHI): a separate HIPAA Research Subject Authorization (RSA) or a compound ICD that includes the required HIPAA elements and language. NOTE: If you are accessing PHI from a military health system database, you will need an approved DSAA prior to beginning research. This DSAA should be accompanied by your HIPAA authorization form, so it is imperative that you use the DHA template (found in the Resource Centers in eIRB) for this and fill out each section completely.
- Request for determination of Exempt IRB Protocol: According to DoD guidelines [link] , the determination of whether a proposed project can be exempt from IRB review is made by an independent Exemption Determination Official (EDO). Instructions on how to request an exemption determination are in the following document (link). It is the policy of the Research Regulatory Oversight Office that PIs are not to make determinations on their own research or anyone else's research.
- For exempt studies involving PHI: Request for a HIPAA Waiver of authorization, Request for Limited Data Set(LDS)/Data Use Agreement(DUA), information sheet to accompany a survey/questionnaire.
- For research activities taking place outside of USU: Site permission letters or permission requests; Data Sharing Agreement or Material Transfer Agreement; if conducting research on a military installation where Service Members are being tartgeted for recruitment, you will need a letter of support from the Commander.
- For subject recruitment: Recruitment materials including advertisements, flyers, telephone or verbal scripts, letters or other communication directed at potential participants.
- For Data collection: Case Report Forms, Case History Forms, Data Collection Instruments, forms for testing tools, surveys, questionnaires.
- For studies involving external collaborators: copies of the signed or final draft or the of the Data Sharing Agreement, Material Transfer Agreement, approved Statement of Work (SOW) for studies with contracts or funded grants , Memorandum of Understanding.
- For studies involving School of Medicine (SOM) or Graduate School of Nursing (GSN) students: Use of SOM Students Approval Form, Use of GSN Students Approval Form.
- For FDA regulated research: FDA Form 1572 (for investigational new drug studies), FDA IND or IDE related correspondence, GCP certificates, current health care provider licenses, investigator's brochure (IB) or product inserts.
- DoD Exemption Criteria - 32CFR219.104 [OHRP Decision Charts updated for the 2018 Common Rule]
- Human Subjects Research - Decision Tree [to be updated]
- USU eIRB Guide - Requesting for Determination of Exempt IRB Protocol [link]
- USU eIRB Guide - Initial Submission of a Full Protocol [link]
USU Human Subject Protection Review Process
Summary: Document processing time for the USU Human Subject Protection Office decreased from November 2016 to January 2017 through implementation of new processes and is now at an efficiency equal to or better than published national norms. However, the total time from first submission to outcome determination for research project related documents continues to be delayed by passbacks from the analysts to the study team to address inconsistencies, deficiencies, or errors in the documents. The Office of the Vice President of Research (VPR) developed a plan to reduce passbacks and thereby eliminate avoidable delays.
USUHS has a research compliance program with four components- Human Subject Protection Review, Research Animal Protection Review, Human Anatomic Material Use Review, and Biosafety. All are staffed by trained professionals whose responsibility is to review the quality of submissions prior to the formal peer review process that makes a determination on if and how a research project may proceed.
For Human Subject Protection, if a project is classified as research and if living identifiable people voluntarily provide facts, opinions, or biological material, there are three possible outcomes.
- The project is exempt from Institutional Review Board review and oversight. The determination of whether a project is exempt is made by a certified Exemption Determination Official (EDO) based on specific criteria published in the relevant regulations.
- The project is non-exempt and the material in the submission is limited in scope and considered minimal risk. Such a submission will receive either an expedited review meaning that the Institutional Review Board (IRB) Chair or delegate will review the material and make a determination with the time for review relative to the complexity of the material, or a full board review. Research eligible for expedited review must meet one of 7 categories (for initial reviews) or 2 continuing review categories.
- The project is non-exempt and the submission is either for a new study or contains material that merits discussion by the full IRB at the next scheduled meeting. This type of submission is often referred to as requiring full board review.
A review of IRB submissions over the past year identifies one factor as the major cause for delay in processing- the need to passback the submission to the study team. Although there are multiple reasons for passbacks, the most common are summarized in the following table. No matter the document type, some examples are:
- Records without documents attached
- Missing documents
- Missing information within documents
- Inconsistencies between documents
The best advice for submissions is to be as detailed and informative as possible, carefully and completely addressing the criteria for approval found at 32 CFR 219.111.